TR199801608T2 - Klopidogrel ve bir tromboz �nleyici i�eren kar���mlar - Google Patents

Klopidogrel ve bir tromboz �nleyici i�eren kar���mlar

Info

Publication number
TR199801608T2
TR199801608T2 TR1998/01608T TR9801608T TR199801608T2 TR 199801608 T2 TR199801608 T2 TR 199801608T2 TR 1998/01608 T TR1998/01608 T TR 1998/01608T TR 9801608 T TR9801608 T TR 9801608T TR 199801608 T2 TR199801608 T2 TR 199801608T2
Authority
TR
Turkey
Prior art keywords
mixtures containing
containing clopidogrel
thrombosis inhibitor
clopidogrel
thrombosis
Prior art date
Application number
TR1998/01608T
Other languages
English (en)
Turkish (tr)
Inventor
Bernat Andre
Herbert Jean-Marc
Savi Pierre
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199801608(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi filed Critical Sanofi
Publication of TR199801608T2 publication Critical patent/TR199801608T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36Antigestagens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TR1998/01608T 1996-02-19 1997-02-17 Klopidogrel ve bir tromboz �nleyici i�eren kar���mlar TR199801608T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9602027A FR2744918B1 (fr) 1996-02-19 1996-02-19 Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique

Publications (1)

Publication Number Publication Date
TR199801608T2 true TR199801608T2 (xx) 1998-11-23

Family

ID=9489354

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01608T TR199801608T2 (xx) 1996-02-19 1997-02-17 Klopidogrel ve bir tromboz �nleyici i�eren kar���mlar

Country Status (28)

Country Link
US (1) US5989578A (is)
EP (1) EP0881901B1 (is)
JP (1) JP3662028B2 (is)
KR (1) KR100295345B1 (is)
CN (1) CN1116042C (is)
AT (1) ATE218870T1 (is)
AU (1) AU715655B2 (is)
BR (1) BR9707556A (is)
CA (1) CA2246289C (is)
CZ (1) CZ292363B6 (is)
DE (2) DE122010000030I2 (is)
DK (1) DK0881901T3 (is)
EE (1) EE03513B1 (is)
ES (1) ES2176684T3 (is)
FR (1) FR2744918B1 (is)
HU (1) HU225036B1 (is)
IL (1) IL125848A (is)
IS (1) IS1892B (is)
NO (2) NO317747B3 (is)
NZ (1) NZ331444A (is)
PL (1) PL187292B1 (is)
PT (1) PT881901E (is)
RU (1) RU2184547C2 (is)
SI (1) SI0881901T1 (is)
SK (1) SK284285B6 (is)
TR (1) TR199801608T2 (is)
UA (1) UA51695C2 (is)
WO (1) WO1997029753A1 (is)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002506024A (ja) * 1998-03-13 2002-02-26 メルク エンド カムパニー インコーポレーテッド 急性冠動脈虚血症候群および関連状態に対する併用療法および組成物
CA2332608C (en) 1998-06-17 2010-03-23 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
US6509348B1 (en) 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
NZ526540A (en) * 2000-12-25 2004-11-26 Sankyo Co Medicinal compositions containing aspirin and 2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-flurobenzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine useful in preventing thrombus or embolus diseases
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
FR2832929A1 (fr) * 2001-12-05 2003-06-06 Sanofi Synthelabo Compositions pharmaceutiques contenant un agent antithrombotique et un derive d'amines cycliques
AU2003270861A1 (en) * 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
ATE536889T1 (de) * 2003-07-08 2011-12-15 Accumetrics Inc Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
HUP0400982A2 (en) * 2004-05-17 2006-08-28 Chemor Kutato New veterinary product for honeybees
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
RU2303980C2 (ru) * 2005-06-03 2007-08-10 ОАО "Щелковский витаминный завод" Лекарственная форма с антиагрегационным действием и способ ее изготовления
CN101253179B (zh) * 2005-09-21 2010-12-29 株式会社钟根堂 S-氯吡格雷的树脂酸盐复合物及其制备方法
WO2008048083A1 (es) * 2006-10-17 2008-04-24 Espinosa Abdala Leopoldo De Je Composiciones farmacéuticas para el tratamiento de enfermedades tromboembólicas
DE102006051625A1 (de) 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
CN101686681B (zh) 2007-04-27 2015-04-01 锡德克斯药物公司 包含氯吡格雷和磺基烷基醚环糊精的制剂和其使用方法
JP2011512406A (ja) * 2008-02-22 2011-04-21 ハナル バイオファーマ カンパニー リミテッド 複合製剤
DE102008032361A1 (de) * 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
WO2010132711A1 (en) 2009-05-13 2010-11-18 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
KR20120050437A (ko) 2009-06-25 2012-05-18 테트라, 시아 신규한 아세틸살리실산 염들
WO2011071853A2 (en) 2009-12-07 2011-06-16 Academic Pharmaceuticals Incorporated Parenteral formulation of clopidogrel
CN102389436A (zh) * 2011-09-09 2012-03-28 北京阜康仁生物制药科技有限公司 一种抗血小板聚集的药物组合物
KR101675501B1 (ko) 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
US8513278B2 (en) 2011-11-26 2013-08-20 Academic Pharmaceuticals, Inc. Parenteral dextrose formulation of clopidogrel
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
WO2013133620A1 (en) * 2012-03-09 2013-09-12 Yuhan Corporation Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same
CN103720700A (zh) * 2012-10-10 2014-04-16 江苏威凯尔医药科技有限公司 含有阿斯匹林和维卡格雷的药用组合物
EP2796145B1 (en) 2013-04-22 2017-11-01 CSL Ltd. A covalent complex of von willebrand factor and faktor viii linked by a disulphide bridge
KR101502588B1 (ko) 2013-05-01 2015-03-16 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
JP5905165B2 (ja) * 2013-08-02 2016-04-20 サノフイ アセチルサリチル酸およびクロピドグレルを含む医薬錠剤
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN107698620A (zh) * 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
RU2745774C1 (ru) * 2020-08-14 2021-03-31 Алексей Викторович Марочков Способ лечения пациентов с новой коронавирусной инфекцией (covid-19)
WO2023012479A1 (en) 2021-08-03 2023-02-09 Liqmeds Worldwide Limited An oral pharmaceutical solution of clopidogrel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire

Also Published As

Publication number Publication date
BR9707556A (pt) 1999-07-27
HUP9901144A3 (en) 2001-04-28
SI0881901T1 (en) 2002-10-31
NO317747B3 (no) 2011-10-03
NO317747B1 (no) 2004-12-13
DK0881901T3 (da) 2002-10-07
WO1997029753A1 (fr) 1997-08-21
FR2744918B1 (fr) 1998-05-07
EE03513B1 (et) 2001-10-15
IS4827A (is) 1998-08-18
CZ249998A3 (cs) 1998-11-11
ES2176684T3 (es) 2002-12-01
EE9800247A (et) 1999-02-15
DE69713287D1 (de) 2002-07-18
US5989578A (en) 1999-11-23
PT881901E (pt) 2002-09-30
FR2744918A1 (fr) 1997-08-22
IS1892B (is) 2003-10-20
CA2246289C (fr) 2003-12-16
AU1884497A (en) 1997-09-02
RU2184547C2 (ru) 2002-07-10
IL125848A0 (en) 1999-04-11
KR100295345B1 (ko) 2001-08-07
IL125848A (en) 2000-11-21
HUP9901144A2 (hu) 1999-09-28
CN1211922A (zh) 1999-03-24
NO983812D0 (no) 1998-08-19
SK110598A3 (en) 1999-01-11
DE122010000030I2 (de) 2012-06-21
CZ292363B6 (cs) 2003-09-17
AU715655B2 (en) 2000-02-10
CN1116042C (zh) 2003-07-30
CA2246289A1 (fr) 1997-08-21
DE69713287T2 (de) 2002-12-19
HU225036B1 (en) 2006-05-29
ATE218870T1 (de) 2002-06-15
HK1017850A1 (en) 1999-12-03
PL187292B1 (pl) 2004-06-30
EP0881901A1 (fr) 1998-12-09
DE122010000030I1 (de) 2010-10-21
NO2010015I2 (no) 2012-11-12
KR19990087163A (ko) 1999-12-15
JP3662028B2 (ja) 2005-06-22
JPH11510818A (ja) 1999-09-21
NO2010015I1 (no) 2010-07-26
NO983812L (no) 1998-10-09
NZ331444A (en) 2001-04-27
UA51695C2 (uk) 2002-12-16
SK284285B6 (sk) 2005-01-03
EP0881901B1 (fr) 2002-06-12
PL327923A1 (en) 1999-01-04

Similar Documents

Publication Publication Date Title
TR199801608T2 (xx) Klopidogrel ve bir tromboz �nleyici i�eren kar���mlar
TR200000517T2 (tr) Piperidinoalkanol-Konjesyon azaltıcıdan oluşan kombinasyona yönelik farmasötik kompozisyon.
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
CY1105538T1 (el) Ιατρικη μορφοποιηση αερολυματος
ATE444756T1 (de) Zusammensetzungen umfassend komplexe von tocopherolphosphatderivaten
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
NO303540B1 (no) Sulfonylalkanoylamino-hydroksyetylaminosulfonamider som er nyttige som retrovirale proteaseinhibitorer, farmas°ytiske preparater inneholdende forbindelsene samt anvendelse av forbindelsene for fremstilling av medikamenter
GEP20012442B (en) Irreversible Inhibitors of Tyrosine Kinases
ATE249422T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
EE04022B1 (et) Trombiini inhibiitorite eelravimid, nende valmistamise protsess, neid sisaldav ravimpreparaat ja nende kasutamine raviks
AR002007A1 (es) UNA COMPOSICION TERAPEUTICA DE APLICACION TOPICA QUE CONTIENE UN ANTAGONISTA DE SUSTANCIA P Y UTILIZACION DE DICHO ANTAGONISTA PARA LAPREPARACIóN DE DICHA COMPOSICION PARA DISMINUIR Y/O ELIMINAR UN EFECTO SECUNDARIO IRRITANTE DE UN PRODUCTO CONTENIDO EN LA MISMA.
DK0766665T3 (da) Metalloproteinaseinhibitorer
MY112093A (en) Cosmetic delivery system for salicylic acid and process for preparation of the same.
IS2156B (is) Settar bensensúlfonamíðafleiður sem forlyf fyrir COX-2 tálma, aðferð til þess að búa þær til, lyfjasamsetningar sem innihalda þær og notkun þeirra við framleiðslu lyfja
SE8103594L (sv) N-(vinblastin-23-oyl)aminosyraderivat
FI960032L (fi) Farmaseuttisia koostumuksia vaikeasti liukenevia aktiiviaineita varten
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
FI973419A0 (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
TR199802108T2 (xx) �bandronat i�eren oral farmas�tik bir form�lasyon.
ATE210988T1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
KR960013371A (ko) 약학적 혼합물
DE69828038D1 (de) Lipidkomplexe von sehr unlöslichen platinkomplexen
GEP20033118B (en) Meta-Azacyclic Amino Benzoic Acid Compounds and Derivatives Thereof Being Integrin Inhibitors, Pharmaceutical Composition and Use Thereof
BR9801150A (pt) Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
TR199900789T2 (xx) Oral uygulama i�in valproyik asit ihtiva eden farmas�tik mikro-k�reler.